Insider · CIK 0001413350

Venkatesan Jay

Reports to the SEC for 8 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001413350

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-31	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+21.8K sh	—	—	21,750
2026-06-17	SERSerina Therapeutics, Inc.C Conversion	Director	CConversion	+224K sh	$2.25	+$504K	231,705
2026-06-17	SERSerina Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+15.3K sh	—	—	15,250
2026-06-17	SERSerina Therapeutics, Inc. · Series A Convertible Preferred StockC Conversion	Director	CConversion	−96.5K sh	$2.25	−$217K	0
2026-05-22	SERSerina Therapeutics, Inc.P Purchase	Director	PPurchase	+589 sh	$1.78	+$1,048.42	589
2026-03-31	SERSerina Therapeutics, Inc.A Award	Director	AAward	+7,553 sh	$1.94	+$14.7K	7,553
2025-11-07	SERSerina Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+10K sh	—	—	10,000
2025-05-19	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,900 sh	—	—	7,900
2025-04-08	SERSerina Therapeutics, Inc. · Series A Convertible Preferred StockA Award	Director	AAward	+96.5K sh	$5.18	+$500K	96,525
2025-02-12	SERSerina Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+40K sh	—	—	40,000
2024-11-26	ELTXElicio Therapeutics, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+50K sh	$0.01	+$500	179,581
2024-11-26	ELTXElicio Therapeutics, Inc. · Warrant to Purchase Common StockX Exercise of In-Money	Director	XExercise of In-Money	−50K sh	—	—	0
2024-11-21	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+4,100 sh	—	—	4,100
2024-06-28	ELTXElicio Therapeutics, Inc. · Common WarrantsP Purchase	Director	PPurchase	+50K sh	—	—	50,000
2024-06-28	ELTXElicio Therapeutics, Inc. · Pre-Funded WarrantsP Purchase	Director	PPurchase	+50K sh	$4.99	+$250K	50,000
2024-06-28	ELTXElicio Therapeutics, Inc. · Common WarrantsP Purchase	Director	PPurchase	+50K sh	—	—	50,000
2024-06-28	ELTXElicio Therapeutics, Inc. · Pre-Funded WarrantsP Purchase	Director	PPurchase	+50K sh	$4.99	+$250K	50,000
2024-06-28	ELTXElicio Therapeutics, Inc. · Common WarrantsP Purchase	Director	PPurchase	+50K sh	—	—	50,000
2024-06-28	ELTXElicio Therapeutics, Inc. · Pre-Funded WarrantsP Purchase	Director	PPurchase	+50K sh	$4.99	+$250K	50,000
2024-06-28	ELTXElicio Therapeutics, Inc. · Common WarrantsP Purchase	Director	PPurchase	+50K sh	—	—	50,000
2024-06-28	ELTXElicio Therapeutics, Inc. · Pre-Funded WarrantsP Purchase	Director	PPurchase	+50K sh	$4.99	+$250K	50,000
2024-06-28	ELTXElicio Therapeutics, Inc. · Common WarrantsP Purchase	Director	PPurchase	+50K sh	—	—	50,000
2024-06-28	ELTXElicio Therapeutics, Inc. · Pre-Funded WarrantsP Purchase	Director	PPurchase	+50K sh	$4.99	+$250K	50,000
2023-12-28	ELTXElicio Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+4,100 sh	—	—	4,100
2022-07-15	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+20.1K sh	$0.45	+$9,028.35	238,126
2022-07-15	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−20.1K sh	$0.45	−$9,028.35	70,000
2022-05-25	ELTXElicio Therapeutics, Inc.P Purchase	Director	PPurchase	+11.3K sh	$1.25	+$14.1K	1,891,947
2022-05-24	ELTXElicio Therapeutics, Inc.P Purchase	Director	PPurchase	+32.2K sh	$1.24	+$39.9K	1,721,457
2022-05-20	ELTXElicio Therapeutics, Inc.P Purchase	Director	PPurchase	+50K sh	$1.23	+$61.5K	1,689,257
2022-03-03	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+600K sh	—	—	600,000
2022-03-03	ELTXElicio Therapeutics, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+160K sh	—	—	760,000
2022-01-03	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)A Award	Director, 10% Owner	AAward	+10K sh	—	—	10,000
2021-12-28	ELTXElicio Therapeutics, Inc.P Purchase	Director	PPurchase	+210K sh	$2.66	+$560K	1,639,257
2021-12-27	ELTXElicio Therapeutics, Inc.P Purchase	Director	PPurchase	+66.9K sh	$2.55	+$171K	1,428,920
2021-12-20	ELTXElicio Therapeutics, Inc.P Purchase	Director	PPurchase	+3,527 sh	$2.54	+$8,975.862	1,362,013
2021-12-17	ELTXElicio Therapeutics, Inc.P Purchase	Director	PPurchase	+13.7K sh	$2.54	+$35K	1,358,486
2021-12-16	ELTXElicio Therapeutics, Inc.P Purchase	Director	PPurchase	+27.9K sh	$2.55	+$71K	1,344,744
2021-12-15	ELTXElicio Therapeutics, Inc.P Purchase	Director	PPurchase	+77.6K sh	$2.41	+$187K	1,316,861
2021-09-17	ALPINE IMMUNE SCIENCES, INC.S Sale	Director, 10% Owner	SSale	−400K sh	$9.40	−$3.76M	2,600,980
2021-06-24	ELTXElicio Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−41.1K sh	$13.78	−$566K	1,239,257
2021-03-31	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+7,650 sh	$3.62	+$27.7K	218,063
2021-03-31	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−7,650 sh	—	—	0
2021-03-30	ALPINE IMMUNE SCIENCES, INC.M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	+7,650 sh	$4.09	+$31.3K	210,413
2021-03-30	ALPINE IMMUNE SCIENCES, INC.Stock Option (Right to buy)M Exercise/Conversion	Director, 10% Owner	MExercise/Conversion	−7,650 sh	—	—	0
2021-02-09	ELTXElicio Therapeutics, Inc.X Exercise of In-Money	Director	XExercise of In-Money	+396K sh	$6.43	+$2.55M	1,598,440
2021-02-09	ELTXElicio Therapeutics, Inc.S Sale	Director	SSale	−159K sh	$16.00	−$2.55M	1,367,263
2021-02-09	ELTXElicio Therapeutics, Inc.C Conversion	Director	CConversion	+262 sh	$11.57	+$3,031.34	1,439,525
2021-02-09	ELTXElicio Therapeutics, Inc. · Warrant to Purchase Common StockX Exercise of In-Money	Director	XExercise of In-Money	−396K sh	—	—	0
2021-02-09	ELTXElicio Therapeutics, Inc.F Tax Payment	Director	FTax Payment	−32K sh	$16.00	−$511K	1,037,017
2021-02-09	ELTXElicio Therapeutics, Inc.C Conversion	Director	CConversion	+165K sh	—	—	1,202,111

Recent filings

Accepted (ET)
Sep 24
Venkatesan Jay0001413350-26-000009
SEC(opens sec.gov)
Jun 224
Venkatesan Jay0001413350-26-000004
SEC(opens sec.gov)
Apr 214
Venkatesan Jay0001413350-26-000002
SEC(opens sec.gov)
Nov 104
Venkatesan Jay0001413350-25-000004
SEC(opens sec.gov)
May 204
Venkatesan Jay0001601485-25-000088
SEC(opens sec.gov)
Apr 104
Venkatesan Jay0001708599-25-000038
SEC(opens sec.gov)
Feb 134
Venkatesan Jay0001708599-25-000021
SEC(opens sec.gov)
Jan 24/A
Venkatesan Jay0001601485-25-000002
SEC(opens sec.gov)
Nov 294
Venkatesan Jay0001601485-24-000105
SEC(opens sec.gov)
Nov 254
Venkatesan Jay0001601485-24-000095
SEC(opens sec.gov)
Jul 24
Venkatesan Jay0001140361-24-032293
SEC(opens sec.gov)

Companies

Address

C/O ELICIO THERAPEUTICS, INC. 451 D STREET, 5TH FLOOR, SUITE 501

BOSTON, MA, 02210